» Articles » PMID: 23123666

Peritoneal Fibrosis and High Transport Are Induced in Mildly Pre-injured Peritoneum by 3,4-dideoxyglucosone-3-ene in Mice

Abstract

Peritoneal dialysis (PD) solution contains high concentrations of glucose and glucose degradation products (GDPs). One of several GDPs--3,4-dideoxyglucosone-3-ene (3,4-DGE)--was recently identified as the most reactive and toxic GDP in PD fluids. In vitro, 3,4-DGE has been shown to induce mesothelial cell damage; however, its role in peritoneal fibrosis in vivo remains unclear. In the present study, we intraperitoneally administered chlorhexidine gluconate (CG) for mild peritoneal injury, and we then injected 3,4-DGE [38 μmol/L (low concentration) or 145 μmol/L (high concentration)] 5 times weekly for 4 weeks. Significant thickening of the parietal peritoneal membrane was observed only when treatment with low or high concentrations of 3,4-DGE occurred after CG administration, but not when either CG or 3,4-DGE alone was given. The combination of CG and 3,4-DGE also caused upregulation of messenger RNA expression of transforming growth factor β1, connective tissue growth factor, fibronectin, collagen type 1 α1 chain, alpha smooth muscle actin (α-SMA), vascular endothelial growth factor 164, NADPH oxidase 1 and 4, p22phox, p47phox, and gp91phox in peritoneal tissue. Treatment with CG alone was sufficient to cause significant F4/80-positive macrophage infiltration, appearance of α-SMA-positive cells, and vessel formation in the submesothelial layer. Addition of 3,4-DGE markedly enhanced those changes and induced apoptosis, mainly in leukocytes. The concentration of 3,4-DGE in the abdominal cavity declined more rapidly in CG-treated mice than in PBS-treated mice. Peritoneal membrane permeability determined by peritoneal equilibration test showed high transport conditions in peritoneum treated with both CG and 3,4-DGE. These results indicate that, when mild peritoneal damage is already present, 3,4-DGE causes peritoneal thickening and fibrosis, resulting in deterioration of peritoneal membrane function.

Citing Articles

Molecular and Cellular Markers in Chlorhexidine-Induced Peritoneal Fibrosis in Mice.

Brezovec N, Kojc N, Erman A, Hladnik M, Stergar J, Milanic M Biomedicines. 2022; 10(11).

PMID: 36359246 PMC: 9687430. DOI: 10.3390/biomedicines10112726.


Aminoguanidine reduces diabetes-associated cardiac fibrosis.

Magdaleno F, Blajszczak C, Charles-Nino C, Guadron-Llanos A, Vazquez-Alvarez A, Miranda-Diaz A Exp Ther Med. 2019; 18(4):3125-3138.

PMID: 31572553 PMC: 6755450. DOI: 10.3892/etm.2019.7921.


Nano-sized carriers in gene therapy for peritoneal fibrosis .

Igarashi Y, Hoshino T, Ookawara S, Ishibashi K, Morishita Y Nano Rev Exp. 2018; 8(1):1331100.

PMID: 30410706 PMC: 6167028. DOI: 10.1080/20022727.2017.1331100.


Targeting lysyl oxidase reduces peritoneal fibrosis.

Harlow C, Wu X, van Deemter M, Gardiner F, Poland C, Green R PLoS One. 2017; 12(8):e0183013.

PMID: 28800626 PMC: 5553776. DOI: 10.1371/journal.pone.0183013.


Human Peritoneal Mesothelial Cell Death Induced by High-Glucose Hypertonic Solution Involves Ca and Na Ions and Oxidative Stress with the Participation of PKC/NOX2 and PI3K/Akt Pathways.

Simon F, Tapia P, Armisen R, Echeverria C, Gatica S, Vallejos A Front Physiol. 2017; 8:379.

PMID: 28659813 PMC: 5468383. DOI: 10.3389/fphys.2017.00379.

References
1.
Mori K, Lee H, Rapoport D, Drexler I, Foster K, Yang J . Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005; 115(3):610-21. PMC: 548316. DOI: 10.1172/JCI23056. View

2.
Lee H, Yu M, Song J, Ha H . Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int. 2004; 65(4):1170-9. DOI: 10.1111/j.1523-1755.2004.00491.x. View

3.
Fieren M . Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis. Blood Purif. 1996; 14(2):179-87. DOI: 10.1159/000170261. View

4.
Mortier S, Faict D, Lameire N, De Vriese A . Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int. 2005; 67(4):1559-65. DOI: 10.1111/j.1523-1755.2005.00237.x. View

5.
Santamaria B, Ucero A, Reyero A, Selgas R, Ruiz-Ortega M, Catalan M . 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization. Nephrol Dial Transplant. 2008; 23(10):3307-15. DOI: 10.1093/ndt/gfn273. View